Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5420)
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
66
Price
$91.00
Total Value
$6.01K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
2,792
Price
$91.00
Total Value
$254.07K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
13,935
Price
$90.17
Total Value
$1.26M
Shares Held After
443
% of Holdings
96.9%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
72,036
Price
$90.17
Total Value
$6.50M
Shares Held After
2,289
% of Holdings
96.9%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
2,090
Price
$90.17
Total Value
$188.46K
Shares Held After
66
% of Holdings
96.9%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
87,848
Price
$90.17
Total Value
$7.92M
Shares Held After
2,792
% of Holdings
96.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$555.76
Total Value
$66.69K
Shares Held After
40,513
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$554.23
Total Value
$354.70K
Shares Held After
40,633
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
801
Price
$553.29
Total Value
$443.19K
Shares Held After
41,273
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,648
Price
$552.38
Total Value
$910.32K
Shares Held After
42,074
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,863
Price
$551.03
Total Value
$1.58M
Shares Held After
43,722
% of Holdings
6.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,452
Price
$550.12
Total Value
$798.78K
Shares Held After
46,585
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,536
Price
$549.01
Total Value
$843.27K
Shares Held After
48,037
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$548.16
Total Value
$241.19K
Shares Held After
49,573
% of Holdings
0.9%
Personalis, Inc. (PSNL)
Hall Christopher M — Director
Shares
100,000
Price
$15.08
Total Value
$1.51M
Shares Held After
235,986
% of Holdings
29.8%
ABEONA THERAPEUTICS INC. (ABEO)
Vasanthavada Madhav — Chief Commercial Officer
Shares
12,606
Price
$6.96
Total Value
$87.78K
Shares Held After
290,623
% of Holdings
4.2%
ABEONA THERAPEUTICS INC. (ABEO)
Seshadri Vishwas — Director
Shares
67,971
Price
$6.96
Total Value
$473.33K
Shares Held After
1,306,108
% of Holdings
4.9%
ABEONA THERAPEUTICS INC. (ABEO)
O'Malley Brendan M. — SVP, Chief Legal Officer
Shares
12,050
Price
$6.96
Total Value
$83.91K
Shares Held After
427,953
% of Holdings
2.7%
ABEONA THERAPEUTICS INC. (ABEO)
Vazzano Joseph Walter — Chief Financial Officer
Shares
24,880
Price
$6.96
Total Value
$173.26K
Shares Held After
493,557
% of Holdings
4.8%
NEUROCRINE BIOSCIENCES INC (NBIX)
Delaet Ingrid — Chief Regulatory Officer
Shares
8,433
Price
$178.72
Total Value
$1.51M
Shares Held After
16,225
% of Holdings
34.2%
CapsoVision, Inc (CV)
HARARI ELIYAHOU ET AL — 10% Owner
Shares
81,300
Price
$6.09
Total Value
$495.12K
Shares Held After
3,282,051
% of Holdings
2.5%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
20,000
Price
$133.63
Total Value
$2.67M
Shares Held After
995,987
% of Holdings
2.0%
PALISADE BIO, INC. (PALI)
Baltera Robert Jr. — Director
Shares
20,000
Price
$1.99
Total Value
$39.80K
Shares Held After
436,904
% of Holdings
4.6%
AN2 Therapeutics, Inc. (ANTX)
Eizen Joshua M — Chief Operating Officer and Chief Legal Officer
Shares
5,945
Price
$4.17
Total Value
$24.80K
Shares Held After
206,554
% of Holdings
2.8%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,500
Price
$0.97
Total Value
$5.33K
Shares Held After
367,485
% of Holdings
1.5%
Seer, Inc. (SEER)
Nishar Dipchand — Director
Shares
10,660
Price
$2.18
Total Value
$23.27K
Shares Held After
59,044
% of Holdings
15.3%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
1,015
Price
$16.00
Total Value
$16.24K
Shares Held After
135,202
% of Holdings
0.7%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
300
Price
$73.69
Total Value
$22.11K
Shares Held After
492,012
% of Holdings
0.1%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
664
Price
$302.46
Total Value
$200.83K
Shares Held After
0
% of Holdings
100.0%
Tempus AI, Inc. (TEM)
Fukushima Ryan — CEO, Data
Shares
2,137
Price
$59.47
Total Value
$127.09K
Shares Held After
167,763
% of Holdings
1.3%
Tempus AI, Inc. (TEM)
Fukushima Ryan — CEO, Data
Shares
3,477
Price
$58.55
Total Value
$203.58K
Shares Held After
169,900
% of Holdings
2.0%
Tempus AI, Inc. (TEM)
Fukushima Ryan — CEO, Data
Shares
13,686
Price
$57.37
Total Value
$785.17K
Shares Held After
173,377
% of Holdings
7.3%
Tempus AI, Inc. (TEM)
Fukushima Ryan — CEO, Data
Shares
13,984
Price
$56.80
Total Value
$794.29K
Shares Held After
187,063
% of Holdings
7.0%
Bicara Therapeutics Inc. (BCAX)
Hyep Ivan — Chief Financial Officer
Shares
830
Price
$30.31
Total Value
$25.16K
Shares Held After
129,855
% of Holdings
0.6%
Bicara Therapeutics Inc. (BCAX)
Hyep Ivan — Chief Financial Officer
Shares
4,413
Price
$29.82
Total Value
$131.62K
Shares Held After
130,685
% of Holdings
3.3%
Bicara Therapeutics Inc. (BCAX)
Hyep Ivan — Chief Financial Officer
Shares
22,757
Price
$28.60
Total Value
$650.90K
Shares Held After
135,098
% of Holdings
14.4%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
1,075
Price
$30.35
Total Value
$32.63K
Shares Held After
182,177
% of Holdings
0.6%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
4,306
Price
$29.80
Total Value
$128.30K
Shares Held After
183,252
% of Holdings
2.3%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
22,833
Price
$28.76
Total Value
$656.65K
Shares Held After
187,558
% of Holdings
10.9%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
77
Price
$39.99
Total Value
$3.08K
Shares Held After
208,198
% of Holdings
0.0%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
1,399
Price
$39.53
Total Value
$55.30K
Shares Held After
208,275
% of Holdings
0.7%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
105
Price
$39.99
Total Value
$4.20K
Shares Held After
209,674
% of Holdings
0.1%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
1,906
Price
$39.53
Total Value
$75.34K
Shares Held After
209,779
% of Holdings
0.9%
Immunovant, Inc. (IMVT)
Van Tuyl Christopher — Chief Legal Officer
Shares
63
Price
$39.99
Total Value
$2.52K
Shares Held After
179,391
% of Holdings
0.0%
Immunovant, Inc. (IMVT)
Van Tuyl Christopher — Chief Legal Officer
Shares
1,143
Price
$39.53
Total Value
$45.18K
Shares Held After
179,454
% of Holdings
0.6%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
106
Price
$39.99
Total Value
$4.24K
Shares Held After
222,357
% of Holdings
0.0%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
1,930
Price
$39.53
Total Value
$76.29K
Shares Held After
222,463
% of Holdings
0.9%
Aktis Oncology, Inc. (AKTS)
Ron-Bigger Shulamit — Chief Operating Officer
Shares
4,200
Price
$28.75
Total Value
$120.74K
Shares Held After
0
% of Holdings
100.0%
Aktis Oncology, Inc. (AKTS)
Czibere Akos — Chief Medical Officer
Shares
4,371
Price
$28.71
Total Value
$125.48K
Shares Held After
0
% of Holdings
100.0%
Aktis Oncology, Inc. (AKTS)
Ron-Bigger Shulamit — Chief Operating Officer
Shares
30,000
Price
$27.94
Total Value
$838.14K
Shares Held After
4,200
% of Holdings
87.7%
Showing 601–650 of 5420 transactions (page 13 of 109)